New eczema ointment takes first step in human safety trial
NCT ID NCT07684937
First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time
Summary
This early-stage trial tests whether HL-300 ointment is safe and tolerable when applied to the skin of healthy adult volunteers. Researchers will give single or multiple doses of the ointment or a placebo to 36 participants aged 18 to 45 in China. The study monitors for side effects and how the body processes the drug, laying groundwork for future testing in people with atopic dermatitis (eczema).
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- HL-300 ointment
- What this could lead to
- If safe, this could lead to a new topical treatment for atopic dermatitis (eczema) that helps control symptoms.
- What could go wrong
- This is an early Phase 1 safety trial in healthy people, not patients. It does not test effectiveness, and the ointment may cause skin irritation or other side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a common antibiotic boost eczema treatment?
- New biologic drug aims to clear stubborn eczema in just 24 weeks
- Skin disease evolution under the microscope: a 17-Year look at what drives severity
- Could a simple body wash and cream soothe eczema without a prescription?
- Skin sodium levels may hold clues to eczema in older adults
- Could a daily powder boost skin elasticity and fight fatigue?